IntegraGen SA (EPA:ALINT)
France
· Delayed Price · Currency is EUR 0.170
0.00 (0.00%)
Apr 29, 2026, 4:28 PM CET
IntegraGen Revenue
In the year 2025, IntegraGen had annual revenue of 5.33M EUR, down -38.67%. IntegraGen had revenue of 2.75M in the half year ending June 30, 2025, a decrease of -55.08%.
Revenue
5.33M
Revenue Growth
-38.67%
P/S Ratio
0.21
Revenue / Employee
133.37K
Employees
40
Market Cap
1.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.33M | -3.36M | -38.67% |
| Dec 31, 2024 | 8.70M | -3.91M | -30.99% |
| Dec 31, 2023 | 12.60M | -603.74K | -4.57% |
| Dec 31, 2022 | 13.21M | 1.88M | 16.63% |
| Dec 31, 2021 | 11.32M | 2.32M | 25.82% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Quantum Genomics Société Anonyme | 10.00 |
| TME Pharma | 27.00K |
| Oncodesign Precision Medicine Société anonyme | 1.74M |
| Plant Advanced Technologies | 2.22M |
| NFL Biosciences | 188.00 |
| Poxel | 7.66M |
| Aton | 656.93K |
| Aelis Farma | 2.33M |